Ceftizoxime
From Infogalactic: the planetary knowledge core
| File:Ceftizoxime.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
| Clinical data | |
| Trade names | Cefizox |
| AHFS/Drugs.com | Consumer Drug Information |
| MedlinePlus | a684043 |
| Identifiers | |
| CAS Number | 68401-81-0 Template:CAS |
| ATC code | J01DD07 (WHO) |
| PubChem | CID: 6533629 |
| ChemSpider | 5018818 |
| UNII | C43C467DPE  |
| KEGG | D07658 |
| ChEMBL | CHEMBL528 |
| Chemical data | |
| Formula | C13H13N5O5S2 |
| Molecular mass | 383.405 g/mol |
Ceftizoxime is a third-generation cephalosporin available for parenteral administration. Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to prevent deactivation by hydrolytic enzymes. It rather resembles cefotaxime in its properties, but is not subject to metabolism. It was removed from the US Market in 2007.
Synthesis
Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.
File:Ceftizoxime synthesis.svg
Ceftizoxime synthesis:[1]
References
- ↑ T. Takaya et al., DE 2810922; eidem, U.S. Patent 4,427,674 (1978, 1984 both to Fujisawa).
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics
- Thiazoles
- Antibiotic stubs
